Skip to content

IBSA Pharma

Active Private limited companyfounded 2022active for 3 yearsde Meeûssquare 37, 1000 BrusselsKBO/BCE: BE 0795.266.574 subsidiary of

Annual accounts 2025

full format, filed on 19-05-2026, 73 days before the deadline
€252,632
▼ 20.6%
€18,750
▼ 10.7%
€1,299
▼ 78.8%
€34,853
▲ 3.9%
48.6%
▲ 11.6 percentage points
1.95
▲ 0.36

Turnover is estimated at about €1.2m, probably between €910,000 and €1.7m.

Balance sheet

balance sheet total €71,733 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

48.6%

Higher than 55% of the 3,805 companies filing full accounts in wholesale trade (NACE 46) in 2025.

1.95

Higher than 58% of the 3,771 companies filing full accounts in wholesale trade (NACE 46) in 2025.

1.8%

Higher than 36% of the 3,803 companies filing full accounts in wholesale trade (NACE 46) in 2025.

IBSA Pharma Middle half of the sector 80% of the sector Full accounts in wholesale trade (NACE 46)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter · Staff: bottom quarter

Staff

€116,709

Staff costs divided by the average number of full-time equivalents.

level

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023
-11,05716,394-
34,85333,55427,438
48.6%37.0%31.4%
1.951.591.46
1.061.712.18
3.7%18.2%8.9%
1.8%6.7%2.8%

EBIT margin not included in this filing.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023
Balance sheet: assets
20/58 71,73390,79987,334
29/58 71,73390,79987,334
40/41 49,58856,95371,927
40 48,00543,90066,750
41 1,58313,0535,177
54/58 20,59731,65315,259
490/1 1,5482,193148
Balance sheet: equity and liabilities
10/49 71,73390,79987,334
10/15 34,85333,55427,438
10/11 25,00025,00025,000
14 9,8538,5542,438
17/49 36,88057,24559,896
42/48 36,88057,24559,896
44 6,4829,93931,854
440/4 6,4829,93931,854
45 30,39847,30628,042
450/3 15,80224,67416,803
454/9 14,59622,63311,239
Income statement
9900 252,632317,984100,159
62 233,418296,97991,752
640/8 465--
9901 18,75021,0068,407
75/76B 01-
75 01-
65/66B 6,7597,0161,794
65 6,7597,0161,794
9903 11,99113,9906,612
67/77 10,6927,8754,174
9904 1,2996,1162,438
9905 1,2996,1162,438
Appropriation of the result
9906 9,8538,5542,438
14P 8,5542,438-
Social balance sheet
9087 222
Hours worked1013 2,9323,2121,784
Document PDFPDFPDF

The full notes are in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 19-05-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 full format 19-05-2026 2026-00117896 PDF
31-12-2024 full format 08-05-2025 2025-00092338 PDF
31-12-2023 full format 29-07-2024 2024-00310963 PDF

Social balance sheet

Item31-12-202531-12-202431-12-2023
Employees at the balance-sheet date222
full-time222
part-time000
in full-time equivalents222
222
On a permanent contract212
Joined112
Left110

Source: social balance sheet in the 2023 to 2025 annual accounts

Insights on IBSA Pharma

The operating result for 2025 is 11% lower than in 2024.

Debt's share of the balance-sheet total falls from 63.0% to 51.4%. Equity is higher and debt is lower.

Next steps